160 related articles for article (PubMed ID: 29600505)
21. Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy.
Lorenzoni V; Baccetti F; Genovese S; Torre E; Turchetti G
Clinicoecon Outcomes Res; 2017; 9():699-710. PubMed ID: 29200879
[TBL] [Abstract][Full Text] [Related]
22. Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil.
Lamounier RN; Geloneze B; Leite SO; Montenegro R; Zajdenverg L; Fernandes M; de Oliveira Griciunas F; Ermetice MN; Chacra AR;
Diabetol Metab Syndr; 2018; 10():83. PubMed ID: 30479669
[TBL] [Abstract][Full Text] [Related]
23. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
24. Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes.
Elliott L; Fidler C; Ditchfield A; Stissing T
Diabetes Ther; 2016 Mar; 7(1):45-60. PubMed ID: 26886441
[TBL] [Abstract][Full Text] [Related]
25. Cost Calculation for a Flash Glucose Monitoring System for Adults with Type 2 Diabetes Mellitus Using Intensive Insulin - a UK Perspective.
Hellmund R; Weitgasser R; Blissett D
Eur Endocrinol; 2018 Sep; 14(2):86-92. PubMed ID: 30349600
[No Abstract] [Full Text] [Related]
26. Clinical implications and economic impact of accuracy differences among commercially available blood glucose monitoring systems.
Budiman ES; Samant N; Resch A
J Diabetes Sci Technol; 2013 Mar; 7(2):365-80. PubMed ID: 23566995
[TBL] [Abstract][Full Text] [Related]
27. [Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)].
Zďarská DJ; Brož J; Křivská B; Rušavý Z; Kvapil M
Vnitr Lek; 2014 Sep; 60(9):712-9. PubMed ID: 25294758
[TBL] [Abstract][Full Text] [Related]
28. The Cost of Hypoglycemia Associated With Type 2 Diabetes Mellitus in Taiwan.
Strizek A; Chang CJ; Furnback W; Wang B; Lebrec J; Lew T
Value Health Reg Issues; 2019 May; 18():84-90. PubMed ID: 30776767
[TBL] [Abstract][Full Text] [Related]
29. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
[TBL] [Abstract][Full Text] [Related]
30. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries.
Geelhoed-Duijvestijn PH; Pedersen-Bjergaard U; Weitgasser R; Lahtela J; Jensen MM; Östenson CG
J Med Econ; 2013 Dec; 16(12):1453-61. PubMed ID: 24144009
[TBL] [Abstract][Full Text] [Related]
31. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
[TBL] [Abstract][Full Text] [Related]
32. The cost of managing severe hypoglycemic episodes in Type 2 diabetic patients.
Laires PA; Conceição J; Araújo F; Dores J; Silva C; Radican L; Nogueira A
Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):315-25. PubMed ID: 26844705
[TBL] [Abstract][Full Text] [Related]
33. Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries.
Haluzik M; Kretowski A; Strojek K; Czupryniak L; Janez A; Kempler P; Andel M; Tankova T; Boyanov M; Smircic Duvnjak L; Madacsy L; Tarnowska I; Zychma M; Lalic N
Diabetes Ther; 2018 Apr; 9(2):727-741. PubMed ID: 29524189
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective.
Evans M; Wolden M; Gundgaard J; Chubb B; Christensen T
Diabetes Obes Metab; 2014 Apr; 16(4):366-75. PubMed ID: 24373113
[TBL] [Abstract][Full Text] [Related]
35. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
[TBL] [Abstract][Full Text] [Related]
36. The short-term economic burden of gestational diabetes mellitus in Italy.
Meregaglia M; Dainelli L; Banks H; Benedetto C; Detzel P; Fattore G
BMC Pregnancy Childbirth; 2018 Feb; 18(1):58. PubMed ID: 29471802
[TBL] [Abstract][Full Text] [Related]
37. Economic burden of hypoglycemia for type II diabetes mellitus patients in Malaysia.
Aljunid SM; Aung YN; Ismail A; Abdul Rashid SAZ; Nur AM; Cheah J; Matzen P
PLoS One; 2019; 14(10):e0211248. PubMed ID: 31652253
[TBL] [Abstract][Full Text] [Related]
38. Economic impact of hypoglycemia on healthcare in Spain.
Brito-Sanfiel M; Diago-Cabezudo J; Calderon A
Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):649-60. PubMed ID: 21155698
[TBL] [Abstract][Full Text] [Related]
39. Economic burden of diabetes-related hypoglycemia on patients, payors, and employers.
Shi L; Fonseca V; Childs B
J Diabetes Complications; 2021 Jun; 35(6):107916. PubMed ID: 33836965
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
